Newly approved drug effective against lung cancer caused by genetic mutation
President says Argentina to produce Russian COVID vaccine
4 June 2021In rural India, fear of testing and vaccines hampers COVID-19 fight
5 June 2021Newly approved drug effective against lung cancer caused by genetic mutation
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The drug is designed to shut down the effects of the mutation, which is found in about 13% of patients with lung adenocarcinoma, a common type of non-small-cell lung cancer.
